TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 84, 108-117
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81402575)
This publication has 47 references indexed in Scilit:
- Nuclear-Targeted Drug Delivery of TAT Peptide-Conjugated Monodisperse Mesoporous Silica NanoparticlesJournal of the American Chemical Society, 2012
- Intracellular angiotensin II activates rat myometriumAmerican Journal of Physiology-Cell Physiology, 2011
- Short-Chain PEG Mixed Monolayer Protected Gold Clusters Increase Clearance and Red Blood Cell CountsACS Nano, 2011
- Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer CellsACS Nano, 2011
- Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growthJournal of Ovarian Research, 2010
- Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATPCancer Research, 2009
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Polymer conjugates as anticancer nanomedicinesNature Reviews Cancer, 2006
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- The Role of Surfactants in the Reversal of Active Transport Mediated by Multidrug Resistance ProteinsJournal of Pharmaceutical Sciences, 2003